Home / Investments / Trinity Life Sciences

Trinity Life Sciences

  • Investment Year:2021
  • Investment Status:Current
  • Transaction Type:Private Sale
  • Trinity is a global provider of outsourced commercialization solutions for pharmaceutical and biopharmaceutical companies, with specialization in evidence-based solutions and data-driven insights that enable clients to bring complex life-changing therapies to market successfully.

    Deal Partner: Christopher Anderson

    Operating Partner: Matthew Jennings

    Skip to content